APA (7th ed.) Citation

HD, K., J, W., R, E., L, S., EH, B., & DD, M. (2025). Treatment of indolent systemic mastocytosis with sarilumab is not supported in a randomized trial. The journal of allergy and clinical immunology. Global, 4(3), 100498. https://doi.org/10.1016/j.jacig.2025.100498

Chicago Style (17th ed.) Citation

HD, Komarow, Wang J, Eisch R, Scott L, Brittain EH, and Metcalfe DD. "Treatment of Indolent Systemic Mastocytosis with Sarilumab Is Not Supported in a Randomized Trial." The Journal of Allergy and Clinical Immunology. Global 4, no. 3 (2025): 100498. https://doi.org/10.1016/j.jacig.2025.100498.

MLA (9th ed.) Citation

HD, Komarow, et al. "Treatment of Indolent Systemic Mastocytosis with Sarilumab Is Not Supported in a Randomized Trial." The Journal of Allergy and Clinical Immunology. Global, vol. 4, no. 3, 2025, p. 100498, https://doi.org/10.1016/j.jacig.2025.100498.